Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia
Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
To see if megestrol acetate plus rosuvastatin will be superior to reversing the endometrial
lesion to a normal endometrium than megestrol acetate alone in patients with atypical
endometrial hyperplasia (AEH). Considering the large sample size in RCT, we used Simon
two-stage design.